![](https://media.xifin.com/dev/uploads/billing-beat-header.webp)
Correction to CR5404: New Waived Tests for May 2007
May 1, 2007Improvement Amendments of 1988 (CLIA), contained an incorrect CPT for the Gryphus Diagnostics BVBlue test. In both the table in the background section of the Recurring Update Notification attachment and in the waived test list attachment, CR 5404 listed the CPT code for the Gryphus Diagnostics BVBlue as CPT Code: 87899QW.
The CPT code 87899 is for infectious agent activity detection tests by immunoassay with direct optical observation; not otherwise specified. In contrast, the Gryphus Diagnostics BVBlue test is an enzyme activity test that detects sialidase activity in vaginal fluid specimens and is not an immunoassay test. The code in this table and in the waived test list attachment should have been 87999QW (Unlisted microbiology procedure). See the table below for the correct codes. Note: All the other information in CR 5404 remains the same.
CPT Codes for FDA Approved New Waived Tests
CPT Code / Modifier | Description | Effective Date |
82274QW, G0328QW | Immunostics, Inc., hema-screen Specific Immunochemical Fecal Occult Blood Test | June 15, 2006 |
87999QW | Gryphus Diagnostics BVBlue | June 30, 2006 |
83655QW | ESA Biosciences LeadCare II Blood Lead Testing System (whole blood) | September 18, 2006 |